Please assess the completion status of the following clinical trial:

Trial Title: Trivalent Chromium Treatment for Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* rheumatoid arthritis~Exclusion Criteria:~* other autoimmune diseases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Trivalent chromium (Type: ACTIVE_COMPARATOR): A dietary supplement already available in market one of its known uses is to control diabetes.
- Immunesuppressants (Type: ACTIVE_COMPARATOR): Synthetic and/ or biological DMARDs

Based on this trial design, predict the completion outcome and termination type (if applicable).